竹下 勝

Medicine & Life Sciences

1. Rheumatoid Arthritis 100%
2. SARS Virus 72%
3. T-Lymphocytes 52%
4. Neutralizing Antibodies 51%
5. Antibodies 43%
6. Severe Acute Respiratory Syndrome 30%
7. Coronavirus 29%
8. Infliximab 29%
9. Centromere 28%
10. B-Lymphocytes 27%
11. Antigens 26%
12. Serum 26%
13. Interstitial Lung Diseases 25%
14. Matrix Metalloproteinase 3 25%
15. Biomarkers 24%
16. Autoimmune Diseases 23%
17. Methotrexate 22%
18. Anti-Idiotypic Antibodies 21%
19. Helper-Inducer T-Lymphocytes 20%
20. Autoantibodies 20%
21. Vaccination 18%
22. milk fat globule 18%
23. Interleukin-16 18%
24. Coronavirus Infections 16%
25. Antirheumatic Agents 16%
26. Broadly Neutralizing Antibodies 16%
27. Immunoglobulin G4-Related Disease 16%
28. Janus Kinase Inhibitors 16%
29. Cytokines 15%
30. Sendai virus 15%
31. Kinetochores 15%
32. Genes 14%
33. Immune Evasion 14%
34. Etanercept 14%
35. Salivary Glands 14%
36. Monoclonal Antibodies 14%
37. Autoantigens 14%
38. Interleukin-6 14%
39. Th2 Cells 13%
40. Drug Monitoring 13%
41. Alveolar Epithelial Cells 13%
42. HLA-DR Antigens 12%
43. Infections 12%
44. Monocytes 12%
45. Vasculitis 12%
46. Regulatory T-Lymphocytes 11%
47. Synovial Fluid 11%
48. Epidermal Growth Factor 11%
49. Thymus Gland 11%
50. Systemic Lupus Erythematosus 11%